VERU INC. Equity Securities, FV-NI, Realized Gain (Loss)
VERU INC. (VERU) reported Equity Securities, FV-NI, Realized Gain (Loss) of $437.39 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-10.
Financial Statements › Income Statement › Other Income
us-gaap:EquitySecuritiesFvNiRealizedGainLoss · last filed 2026-08-10
- VERU INC. equity securities, fv-ni, realized gain (loss) for the quarter ending 2026-06-30 was $437.39K.
- VERU INC. equity securities, fv-ni, realized gain (loss) for the quarter ending 2026-03-31 was $1.95M.
- VERU INC. equity securities, fv-ni, realized gain (loss) for the quarter ending 2025-06-30 was $0.00.
- VERU INC. equity securities, fv-ni, realized gain (loss) for the quarter ending 2025-03-31 was $0.00.
| Period end | Equity Securities, FV-NI, Realized Gain (Loss) 3 month | Equity Securities, FV-NI, Realized Gain (Loss) 6 month | Equity Securities, FV-NI, Realized Gain (Loss) 9 month |
|---|---|---|---|
| 2026-06-30 | $437.39K 10-Q · filed 2026-08-10 | $2.39M derived: sum of 2 quarters · filed 2026-08-10 | $3.21M 10-Q · filed 2026-08-10 |
| 2026-03-31 | $1.95M 10-Q · filed 2026-05-13 | $2.08M 10-Q · filed 2026-05-13 | |
| 2025-06-30 | $0.00 10-Q · filed 2026-08-10 | $0.00 derived: sum of 2 quarters · filed 2026-08-10 | -$349.08K 10-Q · filed 2026-08-10 |
| 2025-03-31 | $0.00 10-Q · filed 2026-05-13 | -$349.08K 10-Q · filed 2026-05-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Kairos Pharma, LTD. (KAPA) | United States | $0.041B | |
| SCYNEXIS INC (SCYX) | United States | $0.045B | |
| PDS Biotechnology Corp (PDSB) | United States | $0.045B | |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 | |
| Grace Therapeutics, Inc. (GRCE) | $0.046B | -1.83 | |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| Werewolf Therapeutics, Inc. (HOWL) | United States | $0.047B | |
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |